Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
$900M |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
$866M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
$596M |
| 4 |
Clarivate
CLVT
|
$284M |
| 5 |
Mastercard
MA
|
$272M |
Top Sells
| 1 |
Wolfspeed
WOLF
|
$1.11B |
| 2 |
Alphabet (Google) Class C
GOOG
|
$1,000M |
| 3 |
Apple
AAPL
|
$925M |
| 4 |
Intel
INTC
|
$462M |
| 5 |
Microsoft
MSFT
|
$435M |
Sector Composition
| 1 | Technology | 25.57% |
| 2 | Financials | 13.1% |
| 3 | Healthcare | 12.32% |
| 4 | Consumer Discretionary | 12.3% |
| 5 | Communication Services | 9.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3176
Century Therapeutics
IPSC
$40.4M
| $420K | ﹤0.01% |
+16,701
| New | +$420K |
|
3177
FTC Solar
FTCI
$93.3M
| $417K | ﹤0.01% |
4,485
+456
| +11% | +$42.4K |
|
|
AKYA
3178
DELISTED
Akoya BioSciences
AKYA
| $412K | ﹤0.01% |
19,626
+7,525
| +62% | +$158K |
|
3179
Ryvyl
RVYL
$9.23M
| $410K | ﹤0.01% |
4,052
+1,248
| +45% | +$126K |
|
3180
Disc Medicine
IRON
$2.14B
| $404K | ﹤0.01% |
2,824
+745
| +36% | +$107K |
|
3181
Greenwich LifeSciences
GLSI
$157M
| $403K | ﹤0.01% |
9,575
+3,183
| +50% | +$134K |
|
3182
AerSale
ASLE
$399M
| $401K | ﹤0.01% |
30,534
-1,344
| -4% | -$17.7K |
|
3183
Verrica Pharmaceuticals
VRCA
$49.4M
| $399K | ﹤0.01% |
3,279
| – | – |
|
3184
Spok Holdings
SPOK
$371M
| $398K | ﹤0.01% |
+38,963
| New | +$398K |
|
3185
Werewolf Therapeutics
HOWL
$62.6M
| $396K | ﹤0.01% |
19,963
+7,962
| +66% | +$158K |
|
|
CHNGU
3186
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
| – | – |
0
| – | -$355K |
|
3187
Kodak
KODK
$465M
| $395K | ﹤0.01% |
150,811
+14,176
| +10% | +$37.1K |
|
3188
Lazydays
GORV
$9.86M
| $393K | ﹤0.01% |
575
+186
| +48% | +$127K |
|
|
TLIS
3189
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $392K | ﹤0.01% |
3,632
+961
| +36% | +$104K |
|
|
SOS
3190
SOS Ltd
SOS
$11.2M
| $390K | ﹤0.01% |
244
+65
| +36% | +$104K |
|
3191
Celcuity
CELC
$2.3B
| $389K | ﹤0.01% |
18,884
+6,027
| +47% | +$124K |
|
3192
Pioneer Bancorp
PBFS
$329M
| $386K | ﹤0.01% |
29,642
-1,138
| -4% | -$14.8K |
|
3193
Fathom Holdings
FTHM
$55.7M
| $382K | ﹤0.01% |
12,844
| – | – |
|
3194
MeridianLink
MLNK
$1.47B
| $381K | ﹤0.01% |
+17,020
| New | +$381K |
|
3195
Energy Transfer Partners
ET
$60.3B
| $376K | ﹤0.01% |
39,234
-286
| -0.7% | -$2.74K |
|
3196
Monte Rosa Therapeutics
GLUE
$309M
| $373K | ﹤0.01% |
+16,754
| New | +$373K |
|
|
CLPR
3197
Clipper Realty
CLPR
$67.8M
| $365K | ﹤0.01% |
43,912
-13,388
| -23% | -$111K |
|
3198
Kaltura
KLTR
$230M
| $363K | ﹤0.01% |
+35,257
| New | +$363K |
|
|
QIWI
3199
DELISTED
QIWI PLC
QIWI
| $361K | ﹤0.01% |
43,100
+9,200
| +27% | +$77.1K |
|
3200
Advent Technologies
ADN
$10M
| $358K | ﹤0.01% |
1,345
+437
| +48% | +$116K |
|